6.3
[]. Kaevalin Lekhanont, et al. Effects of topical anti-inflammatory agents in a botulinum toxin B-induced mouse model of keratoconjunctivitis sicca. J Ocul Pharmacol Ther. 2007 Feb;23():27-3.
[2]. Nolan JC, et, al. The topical anti-inflammatory and analgesic properties of bromfenac in rodents. Agents Actions. 88 Aug; 25(-2): 77-85.
[3]. Tetsuo Kida, et al. Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits. PLoS One. 20 May 5;(5):e68.
[]. Xiaobo Zhang, et al. Drug-eluting intraocular lens with sustained bromfenac release for conquering posterior capsular opacification. Bioact Mater. 202 Jul 23;:33-357.
[5]. Barry A Schechter, et al. Efficacy and safety of bromfenac for the treatment of corneal ulcer pain. Adv Ther. 200 Oct;27(0):756-6.
H302+H32-H35-H38-H
P26-P270-P273-P280-P302+P352-P330-P3-P50